The publisher, authors, editors, syndication partners, and all distribution platforms make no warranties or representations regarding the completeness, accuracy, or reliability of the information and expressly disclaim any and all liability for any losses, damages, or harm resulting from the use or misuse of any product referenced in this content
By promoting weight loss and addressing associated metabolic abnormalities, weight management therapy plays an important role in mitigating the risk of obesity-related complications
GLP1 GLP1 GLP1 GLP1 GLP1 GLP1
Which is better for weight loss, incretin mimetics or DPP-4 inhibitors
Naunyn-Schmiedeberg's Arch Pharmacol 398 , 56115628 (2025)
[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Latif W., Lambrinos K.J., Patel P., Rodriguez R